ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio
July 12, 2021ProfoundBio announced the closing of a $55+ million Series A financing round led by Lilly Asia Venture and co-led by LYFE Capital, with participation from Sequoia Capital China and Oriza. -
Sciwind Biosciences Secures US$37 Million Series B Financing
February 19, 2021Hangzhou Sciwind Biosciences Co., Ltd. (Sciwind), a clinical-stage, fast-growing biopharmaceutical company focusing on research and development of innovative biologics, today announced the closing of an US$37 Million series B financing.
Pharma Sources Insight January 2025
